Regional excess mortality during the 2020 COVID-19 pandemic in five European countries
- PMID: 35079022
- PMCID: PMC8789777
- DOI: 10.1038/s41467-022-28157-3
Regional excess mortality during the 2020 COVID-19 pandemic in five European countries
Abstract
The impact of the COVID-19 pandemic on excess mortality from all causes in 2020 varied across and within European countries. Using data for 2015-2019, we applied Bayesian spatio-temporal models to quantify the expected weekly deaths at the regional level had the pandemic not occurred in England, Greece, Italy, Spain, and Switzerland. With around 30%, Madrid, Castile-La Mancha, Castile-Leon (Spain) and Lombardia (Italy) were the regions with the highest excess mortality. In England, Greece and Switzerland, the regions most affected were Outer London and the West Midlands (England), Eastern, Western and Central Macedonia (Greece), and Ticino (Switzerland), with 15-20% excess mortality in 2020. Our study highlights the importance of the large transportation hubs for establishing community transmission in the first stages of the pandemic. Here, we show that acting promptly to limit transmission around these hubs is essential to prevent spread to other regions and countries.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




References
-
- Health Organization, W. The true death toll of COVID-19: estimating global excess mortality https://www.who.int/data/stories/the-true-death-toll-of-covid-19-estimat... (2021).
-
- Karanikolos, M. & McKee, M. How comparable is COVID-19 mortality across countries? https://analysis.covid19healthsystem.org/index.php/2020/06/04/how-compar... (2020).
-
- Spiegelhalter, D. Coronavirus deaths: how does Britain compare with other countries? https://www.theguardian.com/commentisfree/2020/apr/30/coronavirus-deaths... (2020).
Publication types
MeSH terms
Grants and funding
- R01HD092580-01A1/Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)
- MR/T025352/1/MRC_/Medical Research Council/United Kingdom
- MR/L01341X/1/MRC_/Medical Research Council/United Kingdom
- R01 HD092580/HD/NICHD NIH HHS/United States
- MR/S019669/1/MRC_/Medical Research Council/United Kingdom